 |
Aqualung Therapeutic
Last updated: July 09, 2024
CEO - Joe GN “Skip” Garcia
USA | Funding: $22.3M (+)
Website: https://www.aqualungtherapeutics.com
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
Website: https://www.aqualungtherapeutics.com
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
